This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Cedars-Sinai Medical Center. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Sajni Josson: Innovator in Cancer Treatment
Introduction
Sajni Josson is a notable inventor based in Los Angeles, CA, who has made significant contributions to the field of cancer treatment. With a focus on innovative methods to combat prostate cancer, her work is paving the way for new therapeutic approaches.
Latest Patents
Sajni Josson holds a patent for her invention titled "Targeting microRNA miR-409-3P to treat prostate cancer." This invention describes methods of treating cancer, cancer metastasis, and drug-resistant cancers using miRNA inhibitors. Specifically, it includes inhibitors of miR-409-5p, miR-409-3p, and miR-154. Additionally, the patent outlines methods of using miRNA as biomarkers to predict responsiveness to cancer drugs and to detect disease states of cancer.
Career Highlights
Sajni Josson is affiliated with Cedars-Sinai Medical Center, where she continues her research and development in cancer therapies. Her dedication to advancing medical science is evident in her innovative approaches to treatment.
Collaborations
Throughout her career, Sajni has collaborated with esteemed colleagues, including Anjali Jain and Leland W K Chung. These partnerships enhance her research and contribute to the collective effort in the fight against cancer.
Conclusion
Sajni Josson's work exemplifies the spirit of innovation in the medical field, particularly in cancer treatment. Her contributions are vital in the ongoing battle against prostate cancer and highlight the importance of research and collaboration in developing effective therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile